Radiation dose to the cochlea has been proposed as a key prognostic factor in hearing preservation following stereotactic radiosurgery (SRS) for vestibular schwannoma (VS). However, understanding of the predictive value of cochlear dose on hearing outcomes following SRS for patients with non-VS tumors of the lateral skull base (LSB) is incomplete. The authors investigated rates of hearing loss following high-dose SRS in patients with LSB non-VS lesions compared with patients with VS.
Patients with LSB meningioma or jugular paraganglioma and serviceable pretreatment hearing who underwent SRS treatment during 2007–2016 and received a modiolus dose > 5 Gy were included in a retrospective cohort study, along with a similarly identified control group of consecutive patients with sporadic VS.
Sixteen patients with non-VS tumors and a control group of 43 patients with VS met study criteria. Serviceable hearing, defined as American Academy of Otololaryngology–Head and Neck Surgery class A/B, was maintained in 13 non-VS versus 23 VS patients (81% vs 56%, p = 0.07). All 3 instances of hearing loss in non-VS patients were observed in cerebellopontine angle (CPA) meningiomas. Non-VS with preserved hearing had a median modiolus dose of 6.9 Gy (range 5.7–19.2 Gy), versus 7.4 Gy (range 5.4–7.6 Gy) in those patients with post-SRS hearing loss (p = 0.53). Sporadic VS patients received an overall median modiolus point-dose of 6.8 Gy (range 5.4–11.7 Gy).
The modiolus dose threshold of 5 Gy does not predict hearing loss in patients with non-VS tumors undergoing SRS, suggesting that dosimetric parameters derived from VS may not be applicable to this population. Differential rates of hearing loss appear to vary by pathology, with paragangliomas and petroclival meningiomas demonstrating decreased risk of hearing loss compared to CPA meningiomas that may directly compress the cochlear nerve similarly to VS.
ABBREVIATIONSAAO-HNS = American Academy of Otololaryngology–Head and Neck Surgery; CPA = cerebellopontine angle; JP = jugular paraganglioma; LSB = lateral skull base; PTA = pure tone average; SDS = speech discrimination score; SRS = stereotactic radiosurgery; TN = trigeminal neuralgia; VS = vestibular schwannoma.
BrownMRuckensteinMBigelowDJudyKWilsonVAlonso-BasantaM: Predictors of hearing loss after Gamma Knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage. Neurosurgery69:605–6142011
CarlsonMLJacobJTPollockBENeffBATombersNMDriscollCL: Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline. J Neurosurg118:579–5872013
HasegawaTKidaYKatoTIizukaHYamamotoT: Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. J Neurosurg115:1078–10862011
HasegawaT, KidaY, KatoT, IizukaH, YamamotoT: Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. 115:1078–1086, 201110.3171/2011.7.JNS1174921961962)| false
JacobJTCarlsonMLSchieferTKPollockBEDriscollCLLinkMJ: Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. Neurosurgery74:466–4742014
JacobJT, CarlsonML, SchieferTK, PollockBE, DriscollCL, LinkMJ: Significance of cochlear dose in the radiosurgical treatment of vestibular schwannoma: controversies and unanswered questions. 74:466–474, 20142447690410.1227/NEU.0000000000000299)| false
KimYH, KimDG, HanJH, ChungHT, KimIK, SongSW, : Radiosurgery for para-IAC meningiomas: the effect of radiation dose to the cochlea on hearing outcome. 84:675–680, 201210.1016/j.ijrobp.2011.12.07822440039)| false
TimmerFCAHanssensPEJvan HarenAEPMulderJJCremersCWBeynonAJ: Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. Laryngoscope119:1076–10812009
TimmerFCA, HanssensPEJ, van HarenAEP, MulderJJ, CremersCW, BeynonAJ, : Gamma knife radiosurgery for vestibular schwannomas: results of hearing preservation in relation to the cochlear radiation dose. 119:1076–1081, 200910.1002/lary.2024519399836)| false
ZachenhoferIWolfsbergerSAichholzerMBertalanffyARoesslerKKitzK: Gamma-Knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. Neurosurgery58:28–362006
ZachenhoferI, WolfsbergerS, AichholzerM, BertalanffyA, RoesslerK, KitzK, : Gamma-Knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. 58:28–36, 200610.1227/01.NEU.0000190654.82265.A3)| false